Pathway Genomics to participate in NASDAQ Fit Week

SAN DIEGO–(BUSINESS WIRE)–#PathwayFit–Pathway Genomics, an innovative commercial-stage genomics company,
announced today that they will be participating in the 7th
annual NASDAQ Fit Week. PathwayFit®, their test that assesses 80 genetic
markers to help personalize and optimize diet, nutrition, metabolic
health and exercise regimes, will be featured at Fit Week. As part of
the event, Pathway will be offering PathwayFit® for a special price of
$199 during the month of January and will also kick off the “This Is My
Pathway” video contest to help create awareness about making informed,
proactive lifestyle decisions.

“Pathway is proud of their partnership with NASDAQ and pleased to be a
part of this event again in 2017,” said Jim
Plante
, Founder & CEO. “We are focused on providing genetic testing
to help people better understand their propensity for risk so they are
able to personalize their healthcare and make positive behavior changes
that lead to improved overall health.”

To learn more about PathwayFit visit www.pathwayfit.com/fit-199,
and to enter the This Is My Pathway video contest for a chance to
win the $1000 Grand Prize visit www.pathwayfit.com/thisismypathway.

About Pathway Genomics

Founded in 2008, Pathway Genomics offers digital healthcare and genetic
testing. Based in San Diego, CA our CLIA and CAP accredited clinical
laboratory provides physicians and their patients in 40+ countries with
actionable and accurate precision healthcare information to improve
health and wellness. The company’s program with IBM Watson is a
smartphone app that merges artificial intelligence and deep learning
with personal genetic information. The app provides users with
personalized health and wellness information based on the individual’s
health history.

Pathway believes in the power of “genetics first” to help make
proactive, informed decisions about health and lifestyle. Our
physician-ordered tests include assays for diet and weight loss,
circulating tumor DNA (liquid biopsy), hereditary cancer,
pharmacogenomics and carrier screening. For more about Pathway Genomics,
visit www.pathway.com
and follow us on Facebook,
LinkedIn
and Twitter.

Contacts

PATHWAY GENOMICS CONTACTS:
Media,
Press & Marketing:

Blythe Lawton, Senior Director, Marketing
858.568.7002
blythe.lawton@pathway.com
or
Investor
Relations:

Kamal Adawi, Chief Financial Officer
858.900.3002
Kamal.Adawi@pathway.com